Slaves, Soldiers, Citizens: African American Artifacts of the Civil War Era

Based on the exhibit Slaves, Soldiers, Citizens: African American Artifacts of the Civil War Era, this book provides the full experience of the exhibit, which was on display in Special Collections at Musselman Library November 2012- December 2013. It also includes several student essays based on specific artifacts that were part of the exhibit. Table of Contents: Introduction Angelo Scarlato, Lauren Roedner ’13 & Scott Hancock Slave Collars & Runaways: Punishment for Rebellious Slaves Jordan Cinderich ’14 Chancery Sale Poster & Auctioneer’s Coin: The Lucrative Business of Slavery Tricia Runzel ’13 Isaac J. Winters: An African American Soldier from Pennsylvania Who Fought at Petersburg Avery Lentz ’14 Basil Biggs: A Prominent African American in Gettysburg after the Battle Lauren Roedner ’13 Linton Ingram: A Former Slave Who Became a Notable African American Educator in Georgia Brian Johnson & Lincoln Fitch ’14 Uncle Tom’s Cabin Theatre Poster: Racism in Post-Emancipation Entertainment Michelle Seabrook ’13 Essay Bibliographies Grand Army of the Republic Exhibit Inventory Acknowledgmentshttps://cupola.gettysburg.edu/libexhibits/1001/thumbnail.jp

Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants

Background: Limited data suggest that higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely-low-birth-weight infants with anemia. Methods: We performed an open, multicenter trial in which infants with a birth weight of 1000 g or less and a gestational age between 22 weeks 0 days and 28 weeks 6 days were randomly assigned within 48 hours after delivery to receive red-cell transfusions at higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge, whichever occurred first. The primary outcome was a composite of death or neurodevelopmental impairment (cognitive delay, cerebral palsy, or hearing or vision loss) at 22 to 26 months of age, corrected for prematurity. Results: A total of 1824 infants (mean birth weight, 756 g; mean gestational age, 25.9 weeks) underwent randomization. There was a between-group difference of 1.9 g per deciliter (19 g per liter) in the pretransfusion mean hemoglobin levels throughout the treatment period. Primary outcome data were available for 1692 infants (92.8%). Of 845 infants in the higher-threshold group, 423 (50.1%) died or survived with neurodevelopmental impairment, as compared with 422 of 847 infants (49.8%) in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95% confidence interval [CI], 0.92 to 1.10; P = 0.93). At 2 years, the higher- and lower-threshold groups had similar incidences of death (16.2% and 15.0%, respectively) and neurodevelopmental impairment (39.6% and 40.3%, respectively). At discharge from the hospital, the incidences of survival without severe complications were 28.5% and 30.9%, respectively. Serious adverse events occurred in 22.7% and 21.7%, respectively. Conclusions: In extremely-low-birth-weight infants, a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity